Drug profile · INN
doxapram hydrochloride
DOXAPRAM HYDROCHLORIDE
doxapram hydrochloride (DOXAPRAM HYDROCHLORIDE) is a potassium channel subfamily k member 9 blocker. Route of administration: injection. Current US regulatory status: approved.
Drug details — doxapram hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
doxapram hydrochloride (DOXAPRAM HYDROCHLORIDE) is a potassium channel subfamily k member 9 blocker. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Potassium channel subfamily K member 9 blocker
Primary target: Potassium channel subfamily K member 3
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is doxapram hydrochloride?
doxapram hydrochloride (DOXAPRAM HYDROCHLORIDE) is a potassium channel subfamily k member 9 blocker. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for doxapram hydrochloride?
DOXAPRAM HYDROCHLORIDE is a marketed brand name for doxapram hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of doxapram hydrochloride?
doxapram hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.